Enzo Biochem (ENZ) Tops Q3 EPS by 1c

Enzo Biochem (NYSE: ENZ) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $18.16 million versus the consensus estimate of $24.5 million.

For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Nvidia underperforms peers as report sparks rack delay worries
• Stifel Starts SpaceX (SPCX) at Buy